Tag: Rejuvenation Roundup

Rejuvenation Roundup October 2026
As the weather cools down, the race for functional interventions heats up, and members of our field have been looking for ways to push through bottlenecks both regulatory and scientific. Here's what we've reported last month. Interviews Laura Minquini on the Quest for Female Longevity: Laura Minquini is not a scientist, but that hasn’t stopped...
Rejuvenation Roundup September 2026
Which generation will be considered "the last to die" of age-related diseases is ultimately a question of technological development and deployment. Here's what's been done on that front in September. Interviews The Last Generation to Die: Interview With Tim Maupin: Filmmaker Tim Maupin has spent a number of years developing The Last Generation to Die,...
Rejuvenation Roundup August 2026
Properly untangling aging means untangling its various counterbalances, sometimes on the individual level. Here's what's been investigated this month. Interviews Wei-Wu He: People Should Become the CEOs of Their Own Health: Wei-Wu He is an unusual combination of scientist and businessman, and his current company focuses on using precision medicine to lengthen people's lives. Michael...
The fight for longevity treatments that measurably improve and lengthen quality of life is ongoing in research, treatment, and policy, with promising successes and a horrifying failure. Here's what's happened in July. Interviews Gabriel Cian on Building the 2060 Longevity Ecosystem: In this follow-up interview, we speak with Gabriel Cian about how the 2060 ecosystem...
Rejuvenation Roundup June 2026
Doing something about aging seems to require action at the most basic genomic level. Here's what's been done there and in other areas in June. Interviews The Thalion Initiative: A New Non-Profit With Big Ambitions: The longevity field remains small and starved for resources, especially the subfield devoted to the fundamental biology of aging, despite...
Rejuvenation Roundup May 2026
Approaches that modify the processes of aging at their roots have gone well beyond basic research and into therapies intended for the clinic within the next few years. Here's how the field has advanced in May. Team and activities The Longevity Investor Network Looks Back at 2025: Through curated monthly pitch sessions, educational seminars, collaborative...